360 related articles for article (PubMed ID: 26740281)
1. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
3. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
Daghestani MH
Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
[TBL] [Abstract][Full Text] [Related]
5. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
6. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters.
Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
8. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
10. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
11. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
13. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
15. Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?
Ozkaya E; Cakir E; Cinar M; Kara F; Baser E; Cakir C; Kucukozkan T
Gynecol Endocrinol; 2012 Jun; 28(6):468-71. PubMed ID: 22103710
[TBL] [Abstract][Full Text] [Related]
16. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.
Dilbaz B; Ozkaya E; Cinar M; Cakir E; Dilbaz S
Endocrine; 2011 Jun; 39(3):272-7. PubMed ID: 21547513
[TBL] [Abstract][Full Text] [Related]
18. Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?
Ersoy AO; Tokmak A; Ozler S; Oztas E; Ersoy E; Celik HT; Erdamar H; Yilmaz N
Arch Gynecol Obstet; 2016 Aug; 294(2):403-9. PubMed ID: 27071619
[TBL] [Abstract][Full Text] [Related]
19. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
20. Serum neudesin levels in patients with polycystic ovary syndrome.
Yilmaz Yasar H; Demirpence M; Colak A; Zeytinli M; Yasar E; Taylan A
Ginekol Pol; 2022; 93(7):525-530. PubMed ID: 34263912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
